Aroldo Dargel

PRECISAI - Precision Psychiatry and AI for Early Intervention and System Innovation in Affective Disorders. 
     My research seeks to advance understanding of how mood disorders develop and affect the brain, body, and daily life over time. I focus on creating actionable tools that harness clinical data to detect early warning signs—empowering patients and clinicians to intervene before full-blown episodes arise.
     Through our program, PRECISAI, we integrate insights from patient care with cutting-edge technologies including artificial intelligence, digital monitoring, and biomedical data. By analyzing electronic health records, biomarkers, and data from wearable devices, we aim to characterize the progression of bipolar and related affective disorders.
     Our goal is to facilitate early identification, deepen scientific understanding of these conditions’ trajectories, and develop tailored, evidence-based interventions that are precise, scalable, and suited to real-world clinical settings. In doing so, we strive to meaningfully improve the lives of individuals at risk for, or living with, mood disorders—as well as the wellbeing of their families.

Selected topics of interest:
Bipolar and other affective disorders | Artificial intelligence in mental health
Digital technologies in mental health | Machine Learning algorithms
Electronic Health Records (EHR) big data | Precision Psychiatry
Early Intervention | Youth Mental Health
Inflammation and cardiometabolic biomarkers | Bio-digital signatures 

Curious minds welcome. If you're a clinician or researcher who shares these goals, we warmly invite you to connect with our vibrant research group. We value innovation, thrive on collaboration, embrace the Francophonie, and pursue rigorous inquiry, always eager to explore new frontiers together.

PRECISAI - Precision Psychiatry and AI for Early Intervention and System Innovation in Affective Disorders. 

My research focuses on improving outcomes for individuals at risk for, or living with, affective disorders, particularly bipolar disorder. Through our program PRECISAI, we combine insights from clinical care with the power of artificial intelligence, digital technology, and health data. By analyzing a wide range of information—including electronic health records, biological markers, and data from wearable devices—we explore how these conditions affect the brain, body, and daily functioning over time.

Our objective is to facilitate the early detection of mood disorders, advance understanding of their developmental trajectories, and develop personalized, evidence-based, data-driven interventions that are clinically precise and adaptable to real-world settings.

Curious minds welcome. Our research group is dedicated to advancing knowledge that meaningfully improves the lives of individuals at risk for, or diagnosed with, bipolar and other affective disorders, as well as their families.

If you're a clinician or researcher who shares these goals, we warmly invite you to connect with our vibrant research group. We value innovation, thrive on collaboration, embrace the Francophonie, and pursue rigorous inquiry, always eager to explore new frontiers together.